The Policy Times (June 4):
The pharmaceutical industries across the developing countries, including Bangladesh, capable of producing vaccines, therapeutics, diagnostics, and other medical equipment, should get licenses as well as the technical know-how to produce the vaccines and health technologies for COVID-19 and those items should be provided to other developing countries free of cost. This was strongly demanded by Bangladesh in the just concluded 74th session of the World Health Assembly (WHA). The 74th WHA was held on 24 May – 1 June 2021 in Geneva virtually and the Bangladesh delegation, led by the Minister for Health and Family Welfare Zahid Maleque, in direct collaboration with the Permanent Mission of Bangladesh in Geneva, attended the event.
At the Assembly, Bangladesh also highlighted the leading role of Prime Minister Sheikh Hasina as a Co-chair of the ‘One Health Global Leaders’ Group on Antimicrobial Resistance’ and emphasized the need to raise global awareness on tackling antimicrobial resistance. In addition, Bangladesh called for paying due attention to the need to promote mental health across the globe and ensure sustainable funding for a strong World Health Organization (WHO).
Bangladesh also participated in the meetings of the WHO Executive Board (EB) and the Program, Budget and Administration Committee (PBAC) as an elected member of both. Health Minister Zahid Maleque was the Rapporteur for the EB session while Ambassador Md. Mustafizur Rahman served as the Vice-Chair of Committee-B of the 74th WHA. A total of 35 resolutions and decisions on various issues related to health were adopted by the WHA.